ATRX loss inhibits DDR to strengthen radio-sensitization in p53-deficent HCT116 cells

Lijing Qin1, Geng Tang1, Ruirui Gui1

  • 1NHC Key Laboratory of Radiobiology (Jilin University), School of Public Health, Jilin University, Changchun, 130021, Jilin, People's Republic of China.

Scientific Reports
|January 4, 2025
PubMed

Insights

Alpha-thalassemia/mental retardation X-linked (ATRX) silencing enhances colorectal cancer (CRC) cell radiosensitivity, particularly when p53 is depleted. ATRX loss promotes apoptosis and DNA damage response, suggesting ATRX as a radiosensitizing target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Radiotherapy is a cornerstone of colorectal cancer (CRC) treatment, but resistance limits efficacy.
  • Identifying novel molecular targets for radiosensitization is crucial for improving patient outcomes.
  • Alpha-thalassemia/mental retardation X-linked (ATRX) is a chromatin remodeler involved in genomic stability, but its role in CRC radiosensitivity is unknown.

Purpose of the Study:

  • To investigate the role of ATRX in the radiosensitivity of colorectal cancer (CRC) cells.
  • To elucidate the underlying molecular mechanisms by which ATRX influences response to ionizing radiation (IR).

Main Methods:

  • Silencing of ATRX in HCT116 CRC cells using shRNA.
  • Irradiation of cells and assessment of DNA damage response (DDR), apoptosis, and senescence.
  • Analysis of the Daxx/MDM2/p53 pathway activation and ATM/Chk2 signaling.

Main Results:

  • ATRX depletion significantly increased radiosensitivity in HCT116 CRC cells, an effect amplified by p53 depletion.
  • ATRX loss led to IR-induced DNA damage and G2/M arrest, with impaired ATM/Chk2 pathway activation.
  • ATRX deficiency promoted apoptosis and attenuated senescence, mediated by upregulation of p53 function via the Daxx/MDM2 pathway.

Conclusions:

  • ATRX plays a critical role in regulating colorectal cancer cell radiosensitivity.
  • ATRX loss impairs the DNA damage response and promotes apoptosis, enhancing radiosensitivity.
  • ATRX represents a potential novel radiosensitizing target for CRC, especially in p53-deficient tumors.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
33.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K